Richmond Pharmacology is proud to announce its participation in TheLiver Meeting 2024, hosted by the American Association for the Study of LiverDiseases (AASLD). This event gathers leading hepatology experts to discussgroundbreaking research and advancements in liver diseases. The conference willfeature a wide range of sessions, including state-of-the-art lectures,workshops, and networking opportunities.
To connect with our team during the event, please reach out to arrange ameeting.
Participant-Centred Recruitment and Retention: Driving Faster Answers in Clinical Trials.
December 18, 2025
Richmond Pharmacology is proud to announce the publication of an editorial by Elizabeth Romano, Director of Communications and Participant Engagement, in the Winter 2025 issue of the Journal for Clinical Studies.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
%202024%20img.png)
.svg){kind=small}
.avif)
